Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents

Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents

US Patent 10221158 · Granted Mar 5, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic inhibitors of CBX chromodomains2025
3-diarylmethylenes and uses thereof2025
Dihydropyridines for the treatment of cognitive impairment or traumatic brain in2025
Dihydropyridines for the treatment of cognitive impairment or traumatic brain in2022
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents2020
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents2020
Compositions and methods for treating cancer2020
Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols2019
Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols2019
Cyclic vinylogous amides as bromodomain inhibitors2019
Cyclic vinylogous amides as bromodomain inhibitors2019
Constrained tricyclic sulfonamides2018